CORRESP 1 filename1.htm amix20241119_corresp.htm

 

Autonomix Medical, Inc.

21 Waterway Avenue, Suite 300

The Woodlands, TX 77380

 

  November 19, 2024

 

VIA EDGAR

 

U.S. Securities and Exchange Commission

Division of Corporate Finance

Washington, DC 20549

 

 

Re:

Autonomix Medical, Inc. Registration Statement on Form S-1 File No. 333-282940

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 of the Securities Act of 1933, as amended, Autonomix Medical, Inc., a Delaware corporation (the “Company”), hereby respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 5:30 P.M. (Eastern Time) on November 21, 2024, or as soon thereafter as possible on such date.

 

 

Very truly yours,

 

Autonomix Medical, Inc.

 

 

 

By: /s/ Trent Smith                  

           Name: Trent Smith

           Title: Chief Financial Officer